Genscript Biotech financials at a glance

+ Portfolio

The revenue of Genscript Biotech is reported as 0.84461 billion Dollars in the fiscal year 2023. The earnings were -0.13 Dollars per share in 2023, which was 0 higher than 2021. And about -0.209 billion Dollars are reported as free cash flow in the financials of Genscript Biotech 2023. No dividends were paid to the shareholders of the Genscript Biotech stock SEHK:1548 in the financial year 2023.

HK$625.70M

Revenue

HK$-0.08

Earnings Per Share

48.60%

Gross Margin %

HK$-,338.69M

Free Cash Flow

Revenue

625.70

Earnings Per Share

-0.08

Gross Margin %

48.60

Free Cash Flow

-,338.69

Financials

Year	Year	TTM	2022	2021	2020	2019	2018	2017	2016	2015
Rev.	Revenue	N/A	HK$625.70M	HK$511.06M	HK$390.85M	HK$273.35M	HK$231.02M	HK$152.65M	HK$114.74M	HK$86.71M
GM %	Gross Margin %	43.91%	48.60%	57.65%	65.47%	65.95%	68.63%	68.52%	66.44%	65.83%
OM	Operating Margin	-68.34%	-70.02%	-77.39%	-52.50%	-48.05%	2.21%	25.93%	21.73%	12.57%
EPS	Earnings Per Share	HK$-0.09	HK$-0.08	HK$-0.08	HK$-0.10	HK$-0.05	HK$0.01	HK$0.02	HK$0.02	HK$0.01
Div.	Dividends	N/A	HK$0.00	HK$0.00	HK$0.00	HK$0.00	HK$0.00	HK$0.00	HK$0.00	HK$0.00
PR %	Payout Ratio %	0	0	-0.00%	-0.00%	0	0.00%	0.00%	0	0.00%
Sha.	Shares	N/AM	2,111.23M	2,095.69M	1,953.28M	1,878.38M	1,835.36M	1,733.61M	1,691.86M	1,600M
OCF	Operating Cash Flow	N/A	HK$-,120.29M	HK$-,136.79M	HK$-,151.09M	HK$0.00M	HK$295.41M	HK$21.37M	HK$33.28M	HK$19.64M
FCF	Free Cash Flow	N/A	HK$-,338.69M	HK$-,274.19M	HK$-,272.99M	HK$-,128.64M	HK$224.61M	HK$-7.83M	HK$24.28M	HK$12.94M
FCFS	Free Cash Flow Per Share	HK$-0.22	HK$-0.16	HK$-0.14	HK$-0.15	HK$-0.08	HK$0.13	HK$-0.00	HK$0.01	HK$0.01

Genscript Biotech financials at a glance

Financials

Discover